Abstract
Objective To investigate the therapeutic values of two types of metoprolol tablets for chronic obstructive pulmonary disease (COPD) complicating with chronic heart failure (CHF) and observe the patients’ prognosis. Methods 60 patients with COPD and CHF treated at our hospital were randomly divided into group A (30 cases) and group B (30 cases). Group A were treated with Metoprolol succinate sustained-release tablets and group B metoprolol tartrate tablets. The therapeutic effects, cardiac function, and adverse reactions in the two groups were compared. Results The effective rate was 96.67% ingroup A and was 80.00% in group B, with a statistical difference (P 0.05). Conclusion Compared with metoprolol tartrate tablets, metoprolol succinate sustained-release tablets is more effective and can promote further improvement of cardiac function, so it is worth being clinically generalized. Key words: CHF; COPD; Metoprolol; Curative effect
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
